Chromosomes 17 and 16 are now live on Minos, bringing the total number of chromosomes in the network to 7. Chr17 carries BRCA1 and TP53, while Chr16 contains key genes implicated in kidney disease and blood disorders.

Next target: Chromosome 22 Chromosome 22 is clinically important. Some mutations here are linked to higher cancer risk, while others can change how people respond to common medications. Every chromosome we add brings Minos closer to a true genome-wide intelligence layer.

Minos Network is leveling up. Chromosome 19 is now rolling out, ahead of schedule. We’re moving beyond chromosome-by-chromosome approach. The network is now evaluating multiple chromosomes in parallel, expanding into new ones while continuously refining those already mapped. A bigger, more ambitious leap toward continuous, genome-wide intelligence.